Rizatriptan Benzoate
Brand names: Maxalt, Maxalt Mlt, Rizatriptan
At a glance
- Medicare prescriptions, 2024
- 421,059
- Medicare drug cost
- $8.5M
- Average cost per prescription
- $20.07
- Clinicians who prescribed it
- 18,282
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
MAXALT ® and MAXALT-MLT ® are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Limitations of Use MAXALT should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with MAXALT, the diagnosis of migraine should be reconsidered before MAXALT is administered to treat any subsequent attacks.
From the FDA-approved prescribing information (label dated January 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Neurology 33.4%
- Family Medicine 22.9%
- Nurse Practitioners 17.6%
- Internal Medicine 13.9%
- Physician Assistants 7.6%
- Pain Medicine 0.9%
- General Practice 0.7%
- Physical Medicine & Rehabilitation (PM&R) 0.4%
- Geriatric Medicine 0.3%
- Child Neurology 0.2%
- Psychiatry 0.2%
- ENT (Otolaryngology) 0.2%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 51% from 2019 to 2024.
Biggest change by state since 2019
- Massachusetts +74%
- Virginia +69%
- Illinois +61%
- Pennsylvania +57%
- Arizona +56%
- Tennessee (smallest change) +31%
- Colorado (smallest change) +38%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 4 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Chartwell Rx, LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 5 mg | white round tablet, 6 mm | CE 298 |
| 10 mg | white round tablet, 8 mm | CE 299 |
Glenmark Pharmaceuticals Inc., USA
| Strength | Looks like | Imprint |
|---|---|---|
| 5 mg | white round tablet, 7 mm | 467 |
| 10 mg | white round tablet, 9 mm | 468 |
Organon LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 10 mg | pink oval tablet, 12 mm | MAXALT MRK 267 |
| 10 mg | white round tablet, 14 mm | |
Remedyrepack Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 10 mg | white round tablet, 8 mm | F25 |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
2 recalls since 2020
- Jul 2025 · Ascend Laboratories, LLC · Class II
CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit. - Oct 2021 · Macleods Pharma USA, Inc · Class III
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.